Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort

Fig. 2

Estimated incidence (95%CI) of SARS-CoV-2 (full CIS), RSV (respiratory pilot), and influenza A/B (respiratory pilot). Note: Time frame covering October 24, 2022–February 13, 2023. SY, school year. Estimates based on a Weibull-ILI survival curve for infection duration. See Additional file 1 for further details on survival distributions (Additional file 1: Table S1, Figure S5)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us